# Shuttle (SHPH) — News

SHPH · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/shph/news

## Recent headlines

- [Wh Smith PLC: Panmure Liberum initiates coverage with buy rating; target price 420p](https://www.ainvest.com/news/wh-smith-plc-panmure-liberum-initiates-coverage-buy-rating-target-price-420p-2610) — AInvest Wire, Oct 12, 2026
  Panmure Liberum has initiated coverage on WH Smith PLC (SMWH), assigning the stock a "buy" rating and setting a target price of 420p per share. The firm's decision follows a comprehensive analysis of the company’s market position, operational performance, and growth potential. While no recent price…
- [Shanghai Pharmaceuticals Holdings - participate in establishment of Shanghai Biomedical Phase II Fund](https://www.ainvest.com/news/shanghai-pharmaceuticals-holdings-participate-establishment-shanghai-biomedical-phase-ii-fund-2607) — AInvest Wire, Jul 17, 2026
  Shanghai Pharmaceuticals Holdings (SHPH) has announced its participation in the establishment of the Shanghai Biomedical Phase II Fund, a new initiative aimed at supporting innovation in the biopharmaceutical sector. The fund, which follows the success of the initial Shanghai Biomedical Fund, is…
- Shuttle Pharmaceuticals dips 16%, prices $4.5M share offering — AInvest Wire, Oct 30, 2024
- **Important** — Shuttle Pharma shares surge 16% — AInvest Wire, Sep 5, 2024
  Shuttle Pharma shares up 16% premarket after Co. announces Phase 2 clinical trial of Ropidoxuridine for glioblastoma now open for enrollment at two sites, receives FDA orphan drug designation, and regains Nasdaq compliance after filing delayed financial reports Shuttle Pharmaceuticals Holdings,…

---

Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).